Kratom is a Southeast Asian tree leaf whose compounds act partly like mild opioids — energizing at low intake, pain-relieving and calming at higher intake. The most consistent reported benefits are pain relief and easing opioid withdrawal, set against physical dependence and withdrawal, constipation, occasional serious liver injury, and danger when mixed with other sedating substances. (Full Review)

Protocol

Dose

~1–5 g whole leaf

Traditional whole-leaf powder or tea, used intermittently rather than around-the-clock.

Frequency

Single dose

A single discrete dose for a defined purpose; splitting into multiple daily doses raises cumulative exposure and dependence risk.

Timing

Low early, high later

Low stimulant-range doses earlier in the day for energy; higher sedating doses later. Account for the 3–9 hour half-life to avoid sleep disruption.

Time to effect

Onset

15–60 min

Noticeable effects for pain or mood on the first dose rather than building over weeks.

Peak

~1–1.5 hrs

Effects peak around 1–1.5 hours after ingestion.

Duration

Several hours

Effects from a single dose generally last several hours, reflecting the 3–9 hour half-life.

Benefits

Medium: Acute pain relief; reduction of opioid withdrawal and cravings

Low: Improved mood and reduced anxiety; energy and reduced fatigue at low doses; favorable metabolic markers

Speculative: Safer analgesia via biased opioid signaling; neuroprotective or longevity-relevant effects

Contraindications

Opioids and other CNS depressants (oxycodone, benzodiazepines, alcohol, sedatives)

Pregnancy or breastfeeding

Active or past opioid-use disorder unless medically supervised

Significant liver disease (Child-Pugh Class B or C)

Seizure disorder

Significant cardiac arrhythmia

Key Interactions

CYP2D6 substrates (fluoxetine, paroxetine, some beta-blockers, dextromethorphan)

CYP3A4 substrates and inhibitors (ketoconazole, ritonavir, grapefruit juice, statins, immunosuppressants)

Serotonergic drugs (SSRIs/SNRIs, linezolid, MAO inhibitors)

Stimulants (amphetamines, high-dose caffeine)

Sedative or serotonergic/opioid-like supplements (kava, valerian, St. John's wort, 5-HTP, poppy-seed products)

Risk & Side Effects

High: Dependence and withdrawal; gastrointestinal and constipation effects

Medium: Liver injury; cardiovascular and seizure events in overdose or polydrug use

Low: Drug–drug interaction toxicity; neonatal withdrawal with use in pregnancy

Speculative: Cognitive or learning effects with heavy chronic use; contaminant-related harm

Monitoring

Marker	Target	Why
ALT	< 25 U/L (men), < 20 U/L (women)	Detects early liver-cell injury
AST	< 25 U/L	Complements ALT for liver injury
ALP	40–100 U/L	Flags cholestatic (bile-flow) liver injury
Total bilirubin	< 1.0 mg/dL	Marks impaired bile flow / severity
GGT	< 25 U/L	Confirms hepatobiliary source of enzyme rise
Lipid panel (LDL, HDL, triglycerides)	LDL < 100 mg/dL, HDL > 50 mg/dL, TG < 100 mg/dL	Tracks the metabolic markers kratom may shift
Fasting glucose	75–90 mg/dL	Baseline metabolic health context

Cadence: Baseline before starting; ~4–8 weeks after starting sustained use, then every 6–12 months, with earlier testing if symptoms appear.

Qualitative Assessment

Pain levels and the dose needed to control them (rising dose for the same relief signals tolerance)
Mood and anxiety, watching for worsening between doses (an early dependence sign)
Sleep quality and any morning withdrawal symptoms
Energy and daytime function
Bowel regularity (constipation as a dose-related effect)
Cravings or difficulty taking planned breaks

Kratom for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment